Spots Global Cancer Trial Database for multicenter study
Every month we try and update this database with for multicenter study cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer | NCT00381836 | Prostatic Neopl... Anemia | Darbepoetin Alf... | 18 Years - | University of Aarhus | |
Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC | NCT02018757 | Carcinoma, Hepa... | TACE containing... TACE containing... | 18 Years - 75 Years | First Hospital of China Medical University | |
Percutaneous Microwave Ablation Under Ultrasound Guidance for Liver Cancer: a Multicenter Analysis | NCT03045952 | Liver Neoplasms | microwave ablat... | - | Chinese PLA General Hospital | |
BNHL-2015 for Children or Adolescents in China | NCT02405676 | Mature B-cell N... | Prednisone,Vinc... Cyclophosphamid... Ifosphamide, Et... Cyclophosphamid... Ifosphamide, Et... Rituximab | - 16 Years | Children's Cancer Group, China | |
Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC | NCT02018757 | Carcinoma, Hepa... | TACE containing... TACE containing... | 18 Years - 75 Years | First Hospital of China Medical University | |
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer | NCT00381836 | Prostatic Neopl... Anemia | Darbepoetin Alf... | 18 Years - | University of Aarhus | |
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis | NCT01684761 | Autoimmune Dise... Multiple Sclero... Secondary Progr... Disease Progres... Brain Atrophy | Tcelna Placebo | 18 Years - 60 Years | Opexa Therapeutics, Inc. | |
Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® | NCT02423863 | Melanoma Head and Neck C... Sarcoma Non-Melanoma Sk... | Hiltonol | 18 Years - | Oncovir, Inc. | |
Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
Local Excision in Downstaged Rectal Cancer | NCT00427375 | Rectal Neoplasm... | local rectal ex... total mesorecta... | 18 Years - | University Hospital, Bordeaux | |
Evaluation of Patient and Lesion Specific Prognostic Factors for Standard Radioimmunotherapy | NCT01151358 | Follicular Lymp... | 18 Years - | University Hospital, Saarland | ||
Local Excision in Downstaged Rectal Cancer | NCT00427375 | Rectal Neoplasm... | local rectal ex... total mesorecta... | 18 Years - | University Hospital, Bordeaux | |
In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® | NCT02423863 | Melanoma Head and Neck C... Sarcoma Non-Melanoma Sk... | Hiltonol | 18 Years - | Oncovir, Inc. | |
Evaluation of Patient and Lesion Specific Prognostic Factors for Standard Radioimmunotherapy | NCT01151358 | Follicular Lymp... | 18 Years - | University Hospital, Saarland | ||
Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer | NCT01608464 | Carcinoma of Es... | irinotecan and ... Cisplatin, fluo... | 14 Years - 75 Years | King Faisal Specialist Hospital & Research Center |